Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Neurosurgery|June 18, 2004
Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomideYuichi Hirose, Makoto Katayama, Mitchel S Berger, et al.Surgery Today|May 23, 2006
Long-term survival after resection of metachronous bilateral adrenal metastases of mucinous gastric carcinoma: report of a caseYasuji Mokuno, Makoto Katayama, Yutaka Ogura, et al.Brain Research|January 25, 2003
Cytokines regulate c-Met expression in cultured astrocytesKenji Shimazaki, Kazunari Yoshida, Yuji Hirose, et al.Cancer Research|June 3, 2005
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescenceYuchi Hirose, Makoto Katayama, Olga K Mirzoeva, et al.Journal of Neuro-Oncology|September 21, 2002
Patched and smoothened mRNA expression in human astrocytic tumors inversely correlates with histological malignancyMasateru Katayam, Kazunari Yoshida, Hisatsugu Ishimori, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 5, 2003
Gliofibrous nodule in the cerebello-medullary fissureKazunari Yoshida, Kenji Hiraga, Hisatsugu Ishimori, et al.Molecular and Cellular Biology|October 31, 2003
The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agentsYuichi Hirose, Makoto Katayama, David Stokoe, et al.Journal of Chromatography. A|August 12, 2008
High-throughput assay of nitric oxide metabolites in human plasma without deproteinization by lab-on-a-chip electrophoresis using a zwitterionic additiveTakashi Miyado, Shin-ichi Wakida, Hitoshi Aizawa, et al.Journal of Neuro-Oncology|May 27, 2015
Upfront chemotherapy and subsequent resection for molecularly defined gliomasHikaru Sasaki, Yuichi Hirose, Takahito Yazaki, et al.Thoracic Cancer|October 21, 2025
Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 FusionMizuha Haraguchi Hashiguchi, Maika Tanino, Suzuyuki Yoneda, et al.Pageof 3